What biopharma companies need to know about this evolving regulatory pathway. The FDA’s latest draft guidance on accelerated approval for new drugs, “Expedited Program for Serious ...
Inizio Engage is expanding its Global Medical Information platform with Connected Insights to convert the more than one million scientific interactions its teams handle annually into actionable ...
FDA reviewers argued RECIST v1.1 response and DoR may be inflated because injected-lesion shrinkage could represent local ...
Formulary decisions commonly restrict access to T2D and weight loss, creating coverage blind spots as GLP-1 trials mature across broader cardiometabolic and organ-protection indications. Utilization ...
This past May, Pharmaceutical Executive reported that CVS Health decided to return Eli Lilly’s Zepbound to its list of ...
Specialty pharma launches depend heavily on data from outside the organization. Distributors, third-party logistics providers ...
In today's Pharmaceutical Executive Daily, a commentary examines why fragmented software tooling causes scientific judgment to get lost across the biologics R&D pipeline, Replimune shares crash nearly ...
Earlier this year, a report from Pharmaceutical Executive detailed the ways in which China is becoming an essential R&D partner for pharma and biotech companies. According to the ...
FDA approval used the 505(b)(2) pathway and Phase III Luminous results to support efficacy, safety characterization, and adhesive performance in women with BMI <30 kg/m². Contraceptive efficacy in the ...
This episode of The Ron Lanton Report examines why the next phase of healthcare innovation will be constrained not by capital or technology, but by people. Framing the discussion ...
TruTechnologies’ Dr. Richard Graham explains where he sees the actual issues that need to be addressed at FDA. FDA’s latest initiative to improve the drug approval process is Project Trialblazer. The ...
Within your prior big pharma employers, AI is now a core competitive capability as it has shortened target identification and optimized molecule design. As building world-class AI drug-discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results